logo

For the Inventor, By the Inventor

Madrid, Spain

Cristobal M Roldan

USPTO Granted Patents = 13

Average Co-Inventor Count = 4.6

ph-index = 4

Forward Citations = 48(Granted Patents)


Company Filing History:

goldMedal9 out of 14 
 
Laboratorios Made, S.a.
 patents
silverMedal3 out of 5 
 
Laboratories Made, S.a.
 patents
bronzeMedal1 out of 1 
 
Laboratories Knoll, S.a.
 patent

Years Active: 1976-1993

Loading Chart...
13 patents (USPTO):Explore Patents
1. 5183821 - Method for treating leukemias using (1993-02-02),
2. 4204063 - N(Aminoalkyl)-naphthalimides and their derivatives (1980-05-20),
3. 4174451 - 2-Furyl-(3,4-dimethyl-2-pyridyl)-carbinol (1979-11-13),
4. 4173705 - 2-(2-Furoyl)-4-methylpyridine and its methyl iodide quaternary salt (1979-11-06),
5. 4172894 - 3-Thienyl-3-methyl-4-pentyl-2-pyridyl-ketone (1979-10-30),
6. 4172201 - Alpha-2,5,9-trimethyl-benzo(b)thiene(2,3-f)morphan and precursor thereof (1979-10-23),
7. 4146720 - N-Aminoethyl-substituted-3-nitronaphthalimides (1979-03-27),
8. 4145424 - 1,4,4A-Trimethyl-1,2,4a,-4b,9a,10a-hexahydro-10H-benzo �b! thieno (1979-03-20),
9. 4111945 - Process for the preparation of (1978-09-05),
10. 4029799 - Certain analgesically active substituted benzyl pyridine compounds (1977-06-14),
11. 4028371 - The compound (1977-06-07),
12. 4001414 - 1,3,4-Trimethyl-2-(3,4,5-trimethoxybenzyl)-1,2,5,6-tetrahydropyridine (1977-01-04),
13. 3962243 - Mepyramine theophylline acetate (1976-06-08),

Title: Cristobal M Roldan: Innovator in Leukemia Treatment

Introduction

Cristobal M Roldan is a prominent inventor based in Madrid, Spain. He has made significant contributions to the field of medical treatments, particularly in the area of leukemia and solid tumors. With a total of 13 patents to his name, Roldan's work has the potential to impact the lives of many patients.

Latest Patents

One of Roldan's latest patents is a method for treating leukemias using N-(2-dimethylaminoethyl)-3-amino-1,8-naphthalimide, which has been identified as an effective agent for the treatment of leukemias and solid tumors. Additionally, he has developed N(Aminoalkyl)-naphthalimides and their derivatives, where N-substituted-3-substituted naphthalimides are prepared by reacting 3-substituted naphthalic acid with a compound having a primary amino group. These naphthalimides possess cytotoxic properties, showcasing Roldan's innovative approach to cancer treatment.

Career Highlights

Throughout his career, Roldan has worked with notable companies such as Laboratorios Made, S.A. His expertise in the pharmaceutical field has allowed him to develop groundbreaking treatments that address critical health issues.

Collaborations

Roldan has collaborated with esteemed colleagues, including Ricardo Granados Jarque and Juan Bosch Cartes. These partnerships have further enhanced his research and development efforts in the medical field.

Conclusion

Cristobal M Roldan is a distinguished inventor whose work in leukemia treatment exemplifies innovation in medicine. His contributions through patents and collaborations continue to pave the way for advancements in cancer therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…